Syra Health EBITDA Margin 2022-2024 | SYRA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Syra Health (SYRA) over the last 10 years. The current EBITDA margin for Syra Health as of September 30, 2024 is .
| Syra Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.01B | $-0.00B | -37.50% |
| 2024-06-30 | $0.01B | $-0.00B | -37.50% |
| 2024-03-31 | $0.01B | $-0.00B | -42.86% |
| 2023-12-31 | $0.01B | $-0.00B | -50.00% |
| 2023-06-30 | $0.00B | $-0.00B | -50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.006B |
| Syra Health Corp. is a healthcare technology company. It offers products and services in digital health, behavioral and mental health, population health management, health education and healthcare workforce. Syra Health Corp. is based in CARMEL, Ind. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.226B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
| Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
| Enovis (ENOV) | United States | $2.608B | 17.68 |
| Privia Health (PRVA) | United States | $2.587B | 215.60 |
| IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
| Azenta (AZTA) | United States | $2.209B | 110.15 |
| Omnicell (OMCL) | United States | $2.116B | 69.23 |
| 10x Genomics (TXG) | United States | $1.732B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.518B | 0.00 |
| Phreesia (PHR) | United States | $1.148B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Talkspace (TALK) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| TruBridge (TBRG) | United States | $0.247B | 71.91 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |